The FDA Is Finally Considering a New Sunscreen Ingredient. Here's What to Know
The FDA is considering the approval of a new sunscreen ingredient called bemotrizinol, which could improve the effectiveness and safety of sunscreens in the U.S. This ingredient has been used in Europe for years and is seen as a potential game-changer for American consumers. The decision on bemotrizinol is expected to be made this summer, following decades without new UV-blocking ingredients being approved in the U.S.
- ▪The FDA announced it is considering bemotrizinol, a new sunscreen ingredient.
- ▪Bemotrizinol has been used in Europe since 2000 and offers broad-spectrum protection.
- ▪Only 550 out of over 2,700 evaluated sunscreens met safety and UV protection criteria according to the Environmental Working Group.
Opening excerpt (first ~120 words) tap to expand
Stop us if you’ve heard this one before: Wear sunscreen. In the U.S., this advice, so commonly bandied about, can be a bit tricky to follow. Compared to other places in the world, manufacturers in the U.S. can use only a handful of ingredients. As a result, many American sunscreens are greasy or leave a white cast on the skin. Others contain substances that may make their way into the bloodstream, according to research, though the health effects of this potential leakage aren’t clear. Finding a product you like and trust enough to wear every day—applying a full shot glass’s worth to the face and skin left exposed by a swimsuit, every two hours, if you’re following the rules—isn’t always simple.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at TIME — Top.
Discussion
0 commentsMore from TIME — Top
